奥美拉唑\阿莫西林\甲硝唑\海洋胃药四联疗法治疗幽门螺旋杆菌相关性消化性溃疡的临床疗效观察
【摘要】目的:探讨四联疗法治疗幽门螺旋杆菌感染(Hp) 相关性消化性溃疡(PU)的疗效。方法:162例幽门螺杆菌阳性的消化性溃疡患者,随机分为治疗组82例及对照组80例。治疗组给予奥美拉唑+甲硝唑+阿莫西林+海洋胃药联合用药方案;对照组用西咪替丁+甲硝唑+阿莫西林+海洋胃药进行治疗,并观察其疗效。结果:治疗组与对照组Hp根除率分别为87.9%、90.5%,差异无显著性(P>0.05);4周后溃疡愈合总有效率分别为95.12%和88.75%,差异有显著性(P<0.05)。结论:奥美拉唑、甲硝唑、阿莫西林、海洋胃药四联疗法具有疗程短、疗效高、值得基层医院推广应用。【关键词】消化性溃疡 幽门螺旋杆菌 奥美拉唑 阿莫西林 甲硝唑 海洋胃药
【Abstract】Objective: To investigate the quadruple therapy for Helicobacter pylori infection (Hp)-related peptic ulcer (PU) of the patients. Methods: 162 cases of Helicobacter pylori positive peptic ulcer patients, 82 cases were randomly divided into treatment group and control group 80 cases. The treatment group received omeprazole + metronidazole + amoxicillin + sea combined regimen stomach; control group, cimetidine + metronidazole + amoxicillin for treatment of marine stomach, and observe its effect. Results: The Hp eradication rate and the control group were 87.9%, 90.5%, the difference was not significant (P> 0.05); 4 weeks after the total effective rate of ulcer healing was 95.12% and 88.75%,There was a significant difference (P <0.05). Conclusions: Omeprazole, metronidazole, amoxicillin, quadruple therapy with marine stomach short course of treatment, efficacy, should promote the use of primary hospital. ......
您现在查看是摘要页,全文长 5474 字符。